Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Jarolim

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Diabetes Care|September 18, 2021
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With DiabetesDavid D Berg, Stephen D Wiviott, Benjamin M Scirica, et al.
JAMA Cardiology|March 1, 2023
Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 TrialThomas A Zelniker, Stephen D Wiviott, Ofri Mosenzon, et al.
Blood Advances|November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cellsTomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
Journal of the American College of Cardiology|March 7, 2020
Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young AdultsAvinainder Singh, Ankur Gupta, Ersilia M DeFilippis, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 31, 2025
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery diseaseSanjay Divakaran, Hendrik J Harms, Matthew Robertson, et al.
JAMA Cardiology|February 28, 2017
The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet StudyCarolyn Y Ho, Sharlene M Day, Steven D Colan, et al.
Circulation|November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF TrialDavid D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
Scientific Reports|April 1, 2025
Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican RepublicBehzad Kiani, Benn Sartorius, Beatris Mario Martin, et al.
Circulation|April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HFSu Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Diabetes Care|September 18, 2021
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With DiabetesDavid D Berg, Stephen D Wiviott, Benjamin M Scirica, et al.
JAMA Cardiology|March 1, 2023
Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 TrialThomas A Zelniker, Stephen D Wiviott, Ofri Mosenzon, et al.
Blood Advances|November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cellsTomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
Journal of the American College of Cardiology|March 7, 2020
Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young AdultsAvinainder Singh, Ankur Gupta, Ersilia M DeFilippis, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 31, 2025
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery diseaseSanjay Divakaran, Hendrik J Harms, Matthew Robertson, et al.
JAMA Cardiology|February 28, 2017
The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet StudyCarolyn Y Ho, Sharlene M Day, Steven D Colan, et al.
Circulation|November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF TrialDavid D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
Scientific Reports|April 1, 2025
Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican RepublicBehzad Kiani, Benn Sartorius, Beatris Mario Martin, et al.
Circulation|April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HFSu Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
Pageof 17